IRIS
BAIOCCHI, LEONARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.893
EU - Europa 1.726
AS - Asia 1.004
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 10
OC - Oceania 4
AF - Africa 1
Totale 30.648
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.886
SG - Singapore 507
UA - Ucraina 355
CN - Cina 338
IE - Irlanda 338
DE - Germania 272
IT - Italia 225
SE - Svezia 156
GB - Regno Unito 127
KR - Corea 102
FI - Finlandia 80
RU - Federazione Russa 64
FR - Francia 44
PL - Polonia 22
BE - Belgio 19
EU - Europa 9
JP - Giappone 9
CZ - Repubblica Ceca 7
IN - India 6
PK - Pakistan 6
CA - Canada 5
IL - Israele 5
CH - Svizzera 4
HK - Hong Kong 4
NL - Olanda 4
TM - Turkmenistan 4
VN - Vietnam 4
AU - Australia 3
BR - Brasile 3
CL - Cile 3
IR - Iran 3
CO - Colombia 2
ES - Italia 2
ID - Indonesia 2
KZ - Kazakistan 2
LV - Lettonia 2
MY - Malesia 2
RO - Romania 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
DM - Dominica 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
IQ - Iraq 1
KG - Kirghizistan 1
KW - Kuwait 1
MD - Moldavia 1
MV - Maldive 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
TR - Turchia 1
TW - Taiwan 1
Totale 30.648
Salva come PNG Salva come JPEG
Città #
Woodbridge 7.910
Wilmington 7.523
Houston 6.682
Fairfield 1.024
Ann Arbor 667
Ashburn 472
Chandler 443
Seattle 439
Singapore 436
Cambridge 371
Jacksonville 325
Dublin 308
Medford 248
Dearborn 167
Beijing 141
Lawrence 118
Santa Clara 117
Rome 101
San Diego 91
Menlo Park 69
New York 62
Zhengzhou 57
Mülheim 52
Seoul 34
Moscow 28
Milan 24
Palo Alto 24
Falls Church 23
Redwood City 23
Kraków 22
Norwalk 21
Boardman 20
Brussels 19
San Mateo 16
University Park 16
Creede 15
Shanghai 15
London 14
Mountain View 14
Nanjing 14
Hefei 13
Saint Petersburg 11
Washington 11
Verona 10
Kilburn 9
Kunming 9
Los Angeles 9
Engelhard 8
Guangzhou 8
Hangzhou 8
Helsinki 8
Nuremberg 8
Colorado Springs 7
Hounslow 7
Miami 7
Tianjin 7
Chiswick 6
Council Bluffs 6
Islington 6
Munich 6
Nanchang 6
Jinan 5
Lahore 5
Auburn Hills 4
Brooklyn 4
Fuzhou 4
Shenyang 4
St. George 4
Toronto 4
Central 3
Changchun 3
Chengdu 3
Detroit 3
Dong Ket 3
Esslingen am Neckar 3
Florence 3
Hebei 3
Indiana 3
Lappeenranta 3
New Bedfont 3
Olomouc 3
Southwark 3
Xian 3
Almaty 2
Atlanta 2
Bagnoregio 2
Bangkok 2
Brno 2
Cassino 2
Changsha 2
Chongqing 2
Cologne 2
Enterprise 2
Fiesole 2
Frankfurt am Main 2
Fremont 2
Henrico 2
Indianapolis 2
Kuala Lumpur 2
Madrid 2
Totale 28.445
Salva come PNG Salva come JPEG
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 505
An unusual endoscopic finding in a patient with melena: Multiple gastric ulcers of regular shape 450
Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease 439
Bile acid depletion and repletion regulate cholangiocyte growth and secretion by a phosphatidylinositol 3-kinase-dependent pathway in rats. 438
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 437
Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans 436
Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct-ligated rats 434
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 427
Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats 421
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 418
Physical examination of the liver: Does it make sense in the third millennium? 414
N-ethyl-tauroursodeoxycholic acid, a novel deconjugation-resistant bile salt analogue: effects of acute feeding in the rat 409
Leptin attenuates ischemia-reperfusion injury in the rat liver. 409
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 408
Comment on the PROVE1 and PROVE2 clinical trials: "I was taking a picture of Rapid Virological Response with telaprevir, but the background is unfocused!". 407
Hepatitis C reinfection after liver transplantation in relation to virus genotype 406
Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension 403
Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha 401
Lamellar bodies coexist with vesicles and micelles in human gallbladder bile. Ursodeoxycholic acid prevents cholesterol crystal nucleation by increasing biliary lamellae 401
Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: a biochemical and ultra-structural study in humans 397
596 395
Reduced acute rejection and side effects with neoral in liver transplantation. 395
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 394
Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients 392
Cholinergic system modulates growth, apoptosis, and secretion of cholangiocytes from bile duct-ligated rats. 392
Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats. 391
Dissolution of human cholesterol gallstones in bile salt/lecithin mixtures: effect of bile salt hydrophobicity and various pHs 391
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 387
Regression of cholangiocyte proliferation after cessation of ANIT feeding is coupled with increased apoptosis. 386
Non-transplant surgical approach to liver-based hereditary haemorrhagic telangiectasia: a first report 385
Liver transplantation for end-stage liver disease related to viral hepatitis 384
Plasma/erythrocyte ribavirin x100 ratio as an indicator of sustained virological response in HCV genotype 1 patients with early virological response 383
Short-Term, Low-Dose Use of Tolvaptan as a Bridge Therapy to Expedite Liver Transplant for Severe Hyponatremic, Cirrhotic Patients With High Model for End-Stage Liver Disease Scores 382
Sequential changes in serum and biliary bile acids after liver transplantation 381
Gastrin inhibits cholangiocyte growth in bile duct-ligated rats by interaction with cholecystokinin-B/Gastrin receptors via D-myo-inositol 1,4,5-triphosphate-, Ca(2+)-, and protein kinase C alpha-dependent mechanisms. 380
Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. 379
Prevention of hepatitis C recurrence after liver transplantation: An update. 377
A survey on mortality from non-variceal upper gastrointestinal bleeding: Is the emergency referral system adequate? 376
null 376
One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation 373
Interferon-alpha treatment of hepatitis D induces tuberculosis exacerbation in an immigrant 372
Composition and aggregational forms of biliary lipids in human bile after short-term administration of Taurohyodeoxycholic acid 370
Different expression of VEGF and EGFL7 in human hepatocellular carcinoma 370
Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients. 368
Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation 367
Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation 366
Immunosuppression-Free Liver Transplantation 363
Tauroursodeoxycholate reduces ischemic damage in human allografts: a biochemical and ultrastructural study 362
Liver transplantation for hepatitis C virus end-stage liver cirrhosis as compared with other nonviral indications 362
Patterns of bile salts and biliary lipids early after liver transplantation differentiate patients with unfavorable graft outcome. 359
Regulation of cholangiocyte bile secretion. 357
TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKC alpha-ezrin pathway 357
Plasma clearance of cholyl-lysyl-fluorescein: a pilot study in humans. 356
Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver. 356
Effect of taurohyodeoxycholic acid, a hydrophilic bile salt, on bile salt and biliary lipid secretion in the rat 356
Gastrin inhibits cholangiocarcinoma growth through increased apoptosis by activation of Ca2+-dependent protein kinase C-alpha. 352
Effect of taurohyodeoxycholic acid on biliary lipid secretion in man: preliminary report 351
Cholangiocarcinoma: Challenges and future needs 349
Randomized study on in situ liver perfusion techniques: gravity perfusion vs high-pressure perfusion 348
Secretin activation of the apical Na+-dependent bile acid transporter is associated with cholehepatic shunting in rats. 344
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. 342
A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation 341
Bile acids with differing hydrophilic-hydrophobic properties do not influence cytokine production by human monocytes and murine Kupffer cells 340
Standard bowel cleansing is highly ineffective in cirrhotic patients undergoing screening colonoscopy 334
Oral S-adenosyl-L-methionine (SAMe) administration enhances bile salt conjugation with taurine in patients with liver cirrhosis 328
Immunosuppression without prednisone after liver transplantion is safe and associated with normal early graft function: preliminary results of a randomized study 328
Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver. 322
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 314
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 301
Importance of liver biopsy findings in immunosuppression management: Biopsy monitoring and working criteria for patients with operational tolerance (OT) 293
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 279
An unusual duodenal polyp causing anemia in a liver-transplanted patient 274
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 256
null 232
Dual role of bile acids on the biliary epithelium: Friend or foe? 188
Possible application of melatonin treatment in human diseases of the biliary tract 168
Liver transplantation for hepatocellular carcinoma: Where do we stand? 159
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 153
Domino liver transplantation: Where are we now? 148
Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplant 144
Liver transplantation in a patient with complete portal vein thrombosis, is there a surgical way out? A case report 136
null 131
Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2−/− mouse model of primary sclerosing cholangitis (PSC) 108
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis 105
Neuroendocrine Changes in Cholangiocarcinoma Growth 92
Cholangiocarcinoma: Bridging the translational gap from preclinical to clinical development and implications for future therapy 90
Pro-inflammatory signalling and gut-liver axis in non-alcoholic and alcoholic steatohepatitis: Differences and similarities along the path 89
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 78
Organoids and spheroids as novel models for studying cholestatic liver injury and cholangiocarcinoma 73
2016 comprehensive update of the Banff working group on liver allograft pathology: Introduction of antibody-mediated rejection 71
Management of cholangiocarcinoma in the third millennium: time to be guided! 66
Natremia and liver transplantation: The right amount of salt for a good recipe 65
The interplay between mast cells, pineal gland, and circadian rhythm: Links between histamine, melatonin, and inflammatory mediators 63
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 63
Kupffer Cells: Inflammation Pathways and Cell-Cell Interactions in Alcohol-Associated Liver Disease 62
Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver Injury 57
Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2/ Mouse Model of Primary Sclerosing Cholangitis 53
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 48
The Dynamic Interplay Between Mast Cells, Aging/Cellular Senescence, and Liver Disease 46
Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment? 43
Totale 30.127
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.417
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.417
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.690 0 0 551 710 648 804 733 688 695 696 535 630
2020/20215.377 543 610 552 667 467 835 676 514 108 179 176 50
2021/20221.543 47 275 100 80 33 223 65 69 106 133 75 337
2022/20231.375 154 111 33 135 126 295 150 91 126 22 100 32
2023/2024549 60 16 61 7 113 111 25 19 11 39 4 83
2024/2025858 88 770 0 0 0 0 0 0 0 0 0 0
Totale 31.019